Patents, Price Controls and Access to New Drugs: How Policy Affects Global Market Entry

Jean Lanjouw

No 61, Working Papers from Center for Global Development

Abstract: We consider how patent rights and price regulation affect whether new drugs are marketed in a country, and how quickly. The analysis covers a large sample of 68 countries at all income levels and includes all drug launches over the period 1982-2002. It uses newly compiled information on legal and regulatory policy, and is the first systematic analysis of the determinants of drug launch in poor countries. Price control tends to discourage rapid product entry, while the results for patents are mixed. There is evidence that local capacity to innovate matters and that international pricing externalities may play a role.

Keywords: patent; drugs; access; market entry; price control (search for similar items in EconPapers)
JEL-codes: D4 D62 I11 I18 K10 K2 (search for similar items in EconPapers)
Pages: 53 pages
Date: 2005-06
New Economics Papers: this item is included in nep-com, nep-hea, nep-ind, nep-ino and nep-mic
References: Add references at CitEc
Citations: View citations in EconPapers (58)

Downloads: (external link)
http://www.cgdev.org/content/publications/detail/2679

Related works:
Working Paper: Patents, Price Controls, and Access to New Drugs: How Policy Affects Global Market Entry (2005)
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:cgd:wpaper:61

Access Statistics for this paper

More papers in Working Papers from Center for Global Development Contact information at EDIRC.
Bibliographic data for series maintained by Publications Manager ().